Download PDF
Klin Padiatr 2006; 218(2): 49-56
DOI: 10.1055/s-2005-836607
Übersichtsarbeit

© Georg Thieme Verlag Stuttgart · New York

Neuromonitoring mittels S100B-Protein: Stellenwert für die Neonatologie, pädiatrische Intensivmedizin und Pädiatrie

The Role of S100B-Protein in Neonatology, Pediatric Intensive Care, and PediatricsS. Meyer1 , S. Gottschling2 , A. Baghai1 , T. Polcher1 , M. Strittmatter3 , L. Gortner1
  • 1Klinik für Allgemeine Pädiatrie und Neonatologie
  • 2Klinik für Pädiatrische Hämatologie und Onkologie
  • 3Klinik für Neurologie mit Stroke Unit, Klinikum Merzig
Further Information

Publication History

Publication Date:
02 August 2005 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

In den letzten Jahren hat die Bestimmung biochemischer Marker (S100B-Protein, Neuronen-spezifische Enolase) zur Prognoseabschätzung nach zerebraler Ischämie und Schädel-Hirn-Trauma zunehmend Eingang in die Klinik gefunden. In der Pädiatrie spielt die Bestimmung von S100B-Protein insbesondere bei Neugeborenen nach perinataler Asphyxie sowie bei Kindern nach Schädel-Hirn-Trauma eine Rolle. Ziel dieser Arbeit ist es, einen Überblick über die klinische Bedeutung von S100B-Protein insbesondere für das Neuromonitoring nach nicht-traumatischen und traumatischen Schädigungen des Gehirns bei Neugeborenen und älteren Kindern zu geben.

Abstract

During the last years neuromonitoring with various biochemical markers such as S100B protein has been introduced into the clinical settings of neonatal and pediatric intensive care. Several investigations have been undertaken to correlate S100B protein concentrations to the diagnosis and prognosis of neonates and children with severe cerebral disorders. This articles gives a review on the current knowledge, indications and limitations on the use of S100B protein after non-traumatic and traumatic brain injury in neonates and children.

Schlüsselwörter

S100B-Protein - Neuromonitoring - perinatale Asphyxie - Schädel-Hirn-Trauma - Prognose - Kinder

Key words

S100B protein - neuromonitoring - asphyxia - brain injury - outcome - children

Literatur

  • 1 Akhtar J I, Spear R M, Senac M O, Peterson B M, Diaz S M. Determination of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain.  Pediatr Crit Care Med. 2003;  4 322-326
    PubMedSearch in Google Scholar
  • 2 Anderson R E, Hansson L O, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100B after cardiopulmonary bypass.  Ann Thorac Surg. 2000;  69 847-850
    CrossrefPubMedSearch in Google Scholar
  • 3 Anderson R E, Hansson L O, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum A1000A1-B and S100BB during cardiac surgery arises from extracerebral sources.  Ann Thorac Surg. 2001;  71 1512-1517
    CrossrefPubMedSearch in Google Scholar
  • 4 Beems T, Simons K S, van Geel W JA, de Reus H PM, Vos P E, Verbeck M M. Serum- and CSF-concentrations of brain-specific proteins in hydrocephalus.  Acta Neurochir. 2003;  145 37-43
    CrossrefPubMedSearch in Google Scholar
  • 5 Berger R. Biomarkers or neuroimaging in central nervous system injury: Will the real “gold standard” please stand up?.  Pediatr Crit Care Med. 2003;  4 391
    PubMedSearch in Google Scholar
  • 6 Berger R P, Pierce M C, Wisnieski S R, Adelson P D, Kochanek P. Serum S100B concentrations are increased after closed head injury in children: a preliminary study.  J Neurotrauma. 2002;  19 1404-1409
    PubMedSearch in Google Scholar
  • 7 Berger R P, Pierce M C, Wisniewski S R, Adelson P D, Clark R SB, Ruppel R A, Kochanek P M. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.  Pediatrics. 2002;  109 e31
    CrossrefPubMedSearch in Google Scholar
  • 8 Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants.  Acta Paediatr. 2001;  90 1171-1175
    CrossrefPubMedSearch in Google Scholar
  • 9 Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate.  Clin Perinatol. 2004;  31 107-116
    CrossrefPubMedSearch in Google Scholar
  • 10 de Vries J, Thijssen W AM, Snels S EA, Menovsky T, Peer N GM, Lamres K JB. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.  J Neurol Neurosurg Psychiatry. 2001;  71 671-674
    PubMedSearch in Google Scholar
  • 11 Dennery P A. Predicting neonatal brain injury. Are we there yet?.  Arch Pediatr Adolesc Med. 2003;  157 1151-1152
    CrossrefPubMedSearch in Google Scholar
  • 12 Donato R. S-100 proteins.  Cell Calcium. 1986;  7 123-145
    CrossrefPubMedSearch in Google Scholar
  • 13 Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.  Int J Biochem Cell Biol. 2001;  33 637-668
    CrossrefPubMedSearch in Google Scholar
  • 14 Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, Pedrazzi E, Bruschettini P. Pediatric concentrations of S100B protein in blood: Age- and sex-related changes.  Clin Chem. 2003;  49 967-970
    PubMedSearch in Google Scholar
  • 15 Gazzolo D, Di Iorio R, Marinoni E, Masetti P, Serra G, Giovanni L, Michetti F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage.  Crit Care Med. 2002;  30 1356-1360
    PubMedSearch in Google Scholar
  • 16 Gazzolo D, Marinoni E, Di Ioria R, Bruschettini M, Kornacka M, Lituania M, Majewska U, Serra G, Michetti F. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants.  Crit Care Med. 2004;  32 131-136
    PubMedSearch in Google Scholar
  • 17 Gazzolo D, Vinesi P, Bartocci M, Geloso M C, Bonacci W, Serra G, Haglid K G, Michetti F. S100 blood level as early indicators of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry.  J Neurol Sci. 1999;  170 32-35
    CrossrefPubMedSearch in Google Scholar
  • 18 Gazzolo D, Marioni E, Di Iorio R, Lituania M, Bruschettini P L, Michetti F. Circulating S100B protein is increased in intrauterine growth retarded fetuses.  Pediatr Res. 2002;  51 215-219
    PubMedSearch in Google Scholar
  • 19 Gazzolo D, Bruschettini M, Corvino V, Oliva R, Sarli R, Lituania M, Bruschetini P, Michetti F. S100B protein concentrations in amniotic fluid are correlated with gestational age and with cerebral ultrasound scanning parameters results in healthy fetuses.  Clin Chem. 2001;  47 954-956
    PubMedSearch in Google Scholar
  • 20 Hermann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring.  Restor Neurol Neurosci. 2003;  21 177-190
    PubMedSearch in Google Scholar
  • 21 Howard A, Legon S, Spurr N K, Walters J RF. Molecular cloning and chromosome assignment of human calbindin-D9K.  Biochem Biophys Res Commun. 1992;  185 663-669
    CrossrefPubMedSearch in Google Scholar
  • 22 Infante J R, Martinez A, Ochoa J, Canadillas F, Torres-Avisbal M, Vallejo J A, Gonzalez F M, Pacheco C, Latre J M. Cerebrospinal fluid S-100 protein levels in neurological pathologies.  J Physiol Biochem. 2003;  59 255-261
    PubMedSearch in Google Scholar
  • 23 Infante J R, Torres-Avisbal M, Martinez A, Vallejo J A, Aguilera C, Contreras P, Benitez A, Latre J M. Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with non-ischemic brain pathologies.  Tumor Biology. 2000;  21 38-45
    CrossrefPubMedSearch in Google Scholar
  • 24 Ingebrigtsen T, Romner S, Marup-Jensen S, Dons M, Lundquist C, Alling C, Borgesen S E. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study.  Brain Inj. 2000;  14 1047-1055
    CrossrefPubMedSearch in Google Scholar
  • 25 Ingebrigsten T, Waterloo K, Jacobson E A, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome.  Neurosurgery. 1999;  45 468-475
    PubMedSearch in Google Scholar
  • 26 Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury.  Restor Neurol Neurosci. 2003;  21 171-176
    PubMedSearch in Google Scholar
  • 27 Isobe T, Ishioka N, Okuyama T. The amino-acid sequence of the α subunit in bovine brain S-100 protein.  Eur J Biochem. 1981;  116 79-86
    CrossrefPubMedSearch in Google Scholar
  • 28 Isobe T, Okuyama T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100-a protein.  Eur J Biochem. 1981;  115 469-474
    PubMedSearch in Google Scholar
  • 29 Isobe T, Okuyama T. The amino-acid sequence of S-100 protein (PAP I-b) and its relationship to calcium-binding proteins.  Eur J Biochem. 1978;  89 379-388
    CrossrefPubMedSearch in Google Scholar
  • 30 Jensen E, Sandstrom K, Andreasson S, Nilsson K, Berggren H, Larsson L E. Increased levels of S-100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children.  Paediatr Anaesth. 2000;  10 297-302
    CrossrefPubMedSearch in Google Scholar
  • 31 Lamers K J, Vos P, Verbeek M M, Rosmalen F, van Geel W J, Engelen B G van. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.  Brain Res Bull. 2003;  15 261-264
    PubMedSearch in Google Scholar
  • 32 Lardner D, Davidson A, McKenzie I, Cochrane A. Delayed rise in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass.  Paediatr Anaesth. 2004;  14 495-500
    PubMedSearch in Google Scholar
  • 33 Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects.  Acta Paediatr. 2002;  91 9-13
    PubMedSearch in Google Scholar
  • 34 Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg M, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D. Peripheral markers of brain damage and blood-brain-barrier dysfunction.  Restor Neurol Neurosc. 2003;  21 109-121
    PubMedSearch in Google Scholar
  • 35 Marks A, Allore R J. S-100 protein and Down syndrome.  Bioessays. 1990;  12 381-383
    CrossrefPubMedSearch in Google Scholar
  • 36 McAdory B S, Eldik L J Van, Norden J J. S100B, a neurotrophic protein that modulates neuronal protein phosphorylation, is up-regulated during lesion-induced collateral sprouting and reactive synaptogenesis.  Brain Res. 1998;  813 211-217
    CrossrefPubMedSearch in Google Scholar
  • 37 Michetti F, Gazzolo D. S100B protein in biological fluids: A tool for perinatal medicine?.  Clin Chem. 2002;  48 2097-2014
    PubMedSearch in Google Scholar
  • 38 Moore B W. A soluble protein characteristic of the nervous system.  Biochem Biophys Res Commun. 1965;  19 739-743
    CrossrefPubMedSearch in Google Scholar
  • 39 Nagdyman N, Grimmer I, Scholz T, Müller M, Obladen M. Predictive value of brain-specific proteins in serum or neurodevelopmental outcome after birth asphyxia.  Pediatr Res. 2003;  54 270-275
    CrossrefPubMedSearch in Google Scholar
  • 40 Nagdyman N, Kömen W, KO H K, Müller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia.  Pediatr Res. 2001;  49 502-506
    PubMedSearch in Google Scholar
  • 41 Ozatik M A, Tarcan O, Kale A, Askin G A, Balci M, Undar A, Kucukaksu D S, Sener E, Tasdemir O. Do S100beta protein level increases due to inflammation due to cardiopulmonary bypass occur without any neurological deficits?.  Perfusion. 2002;  17 335-338
    CrossrefPubMedSearch in Google Scholar
  • 42 Park E S, Park C I, Baek S Y, Kim S W, Baek S K, Kim H O. Serum immunoreactivity to S-100 in children with cerebral palsy and delayed development and in their healthy parents.  Yonsei Med J. 2000;  41 328-332
    PubMedSearch in Google Scholar
  • 43 Park E S, Park C I, Choi K S, Choi I H, Shin J S. Over-expression of S100B protein in children with cerebral palsy or delayed development.  Brain Dev. 2004;  26 190-196
    CrossrefPubMedSearch in Google Scholar
  • 44 Portela L VC, Tort A BL, Schaf D V, Ribeiro L, Nora D B, Walz R, Rotta L N, Silva C T, Busnello J V, Kapczinski F, Goncalves C A, Souza D O. The serum S100B concentration is age-dependent.  Clin Chem. 2002;  48 950-952
    PubMedSearch in Google Scholar
  • 45 Romner B, Ingebrigsten T, Kongstad P, Borgesen S E. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings.  J Neurotrauma. 2000;  17 641-647
    CrossrefPubMedSearch in Google Scholar
  • 46 Schulpis K H, Kariyannis C, Papassotiriou I. Serum levels of neural protein S-100B in phenylketonuria.  Clin Biochem. 2004;  37 76-79
    PubMedSearch in Google Scholar
  • 47 Shaaban A M, Harmer M, Elliot M, Thomas A L, Kirkham F. A pilot study of evaluation of cerebral function by S100beta protein and near-infrared spectroscopy during cold and warm cardiopulmonary bypass in infants and children undergoing open-heart surgery.  Anaesthesia. 2004;  59 20-26
    CrossrefPubMedSearch in Google Scholar
  • 48 Shaaban A M, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery.  Brit J Anaesth. 2000;  85 287-298
    PubMedSearch in Google Scholar
  • 49 Spinella P C, Dominguez T, Drott H E, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M. S-100beta protein serum levels in healthy children and its association with outcome in pediatric traumatic brain injury.  Crit Care Med. 2003;  31 939-945
    PubMedSearch in Google Scholar
  • 50 Spinella P C, Donoghue A, Rajendra A, Drott H R, Dominguez T E, Helfaer M. Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis.  Pediatr Crit Care. 2004;  5 53-57
    PubMedSearch in Google Scholar
  • 51 Synder-Ramos S A, Bottiger B W. Molecular markers of brain damage - clinical and ethical implications with particular focus on cardiac arrest.  Restor Neurol Neurosci. 2003;  21 123-139
    PubMedSearch in Google Scholar
  • 52 Synder-Ramos S A, Gruhlke T, Bauer T, Bauer M, Luntz A P, Motsch J, Martin E, Vahl C F, Missler U, Wiesmann M, Böttiger B W. Cerebral and extracerebral release of protein S100B in cardiac surgical patients.  Anaesthesia. 2004;  59 344-349
    CrossrefPubMedSearch in Google Scholar
  • 53 Unertl K, Kottler M. Prognostische Scores in der Intensivmedizin.  Anaesthesist. 1997;  46 471-480
    CrossrefPubMedSearch in Google Scholar
  • 54 van Passel R, Schlooz W A, Lamers K J, Lemmens W A, Rotteveel J J. S100b protein, glia and Gilles de la Tourette syndrome.  Eur J Paediatr Neurol. 2001;  5 15-19
    CrossrefPubMedSearch in Google Scholar
  • 55 Wainwright M S, Craft J M, Griffin W S, Marks A, Pineda J, Padgett K, Eldik J Van. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia.  Ann Neurol. 2004;  56 61-67
    CrossrefPubMedSearch in Google Scholar
  • 56 Whitelaw A, Rosengren L, Blennow M. Brain specific proteins in posthaemorrhagic ventricular dilatation.  Arch Dis Child (Fetal and Neonatal Ed). 2001;  84 F90-F91
    PubMedSearch in Google Scholar
  • 57 Woertgen C, Rothoerl R D, Holzschuh M Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury.  Acta Neurochir. 1997;  139 1161-1164
    CrossrefPubMedSearch in Google Scholar
  • 58 Woertgen C, Rothoerl R D, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury.  J Trauma. 1999;  47 1126-1130
    PubMedSearch in Google Scholar
  • 59 Wunderlich M T, Ebert A D, Kratz T, Goertler M, Jost S, Hermann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.  Stroke. 1999;  30 1190-1195
    PubMedSearch in Google Scholar
  • 60 Zimmer D B, Cornwall E H, Landar A, Song W. The S100 protein family: history, function, and expression.  Brain Res Bull. 1995;  37 417-429
    CrossrefPubMedSearch in Google Scholar

Dr. med. Sascha Meyer

Klinik für Allgemeine Pädiatrie und Neonatologie · Universitätsklinikum des Saarlandes

Kirrbergerstr. Gebäude 9

66421 Homburg

Phone: +49/68 41/1 62 83 74

Fax: +49/68 41/1 62 83 63

Email: sascha.meyer@uniklinik-saarland.de